FIELD: organic chemistry, medicine, biochemistry, pharmacy.
SUBSTANCE: invention relates to compound of the formula (I) wherein R1 means hydrogen atom, (C1-C6)-alkyl or hydroxy-(C1-C6)-alkyl; R2 means -CO-NR8R9, -(CH2)n-NR8R9, -(CH2)p-OR8 or -(CH2)n-CN; R3 is chosen from hydrogen atom, halogen atom, halogen-(C1-C6)-alkyl; R4, R6 and R7 mean hydrogen atom, fluorine atom and, as minimally, one radical of R4, R5, R6 and R7 means fluorine atom; R8 and R9 mean independently of one another hydrogen atom or (C1-C6)-alkyl; m means 1, 2 or 3; n means 0, 1, 2 or 3; p means 1 or 2, and to their pharmaceutically acceptable salts. Also, invention relates to a medicinal agent possessing inhibitory effect with respect to activity of monoaminoxidase B and comprising one or some compounds of the formula (I) as an active component and pharmaceutically acceptable excipients. Invention proposes derivatives of fluorobenzamide possessing inhibitory effect with respect to activity of monoaminoxidase B.
EFFECT: valuable medicinal and biochemical properties of compounds and pharmaceutical composition.
27 cl, 60 ex
Title | Year | Author | Number |
---|---|---|---|
PYRIDINEAMIDE DERIVATIVES AND MEDICINAL AGENT BASED ON THEREOF | 2003 |
|
RU2309950C2 |
DERIVATIVES OF 4-PYRROLIDINE PHENYL BENZOLE ETHER | 2003 |
|
RU2336268C2 |
2,3-DIHYDROISOINDOL-1-ONES POSSESSING INHIBITORY EFFECT ON MAO B ACTIVITY | 2003 |
|
RU2322437C2 |
DERIVATIVES OF PYRROLIDONE AS MONOAMINE OXIDASE B (MAO B) AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2003 |
|
RU2323209C2 |
DERIVATIVES OF BENZOTHIAZOLE AND MEDICINAL AGENT BASED ON THEREOF | 2002 |
|
RU2301232C2 |
3H-QUINAZOLIN-4-ON DERIVATIVES AND MEDICATION, POSSESSING PROPERTIES OF SPECIFIC MONOAMINOOXIDASE B INHIBITOR | 2003 |
|
RU2340604C2 |
PHTHALIMIDO-DERIVATIVES AS MONOAMINE OXIDASE B INHIBITORS | 2003 |
|
RU2317289C2 |
DERIVATIVES OF DIHYDROBENZO[b][1,4]DIAZEPINE-2-ONE AS ANTAGONISTS OF MGLUR2 II | 2002 |
|
RU2263112C2 |
3-AMINOPYRIDINES AS GPBAR1 AGONISTS | 2012 |
|
RU2594886C2 |
DIAZASPIROPIPERIDINE DERIVATIVES AS GLYCINE CARRIER 1 AND GLYCINE CARRIER 2 INHIBITORS | 2004 |
|
RU2351599C2 |
Authors
Dates
2008-01-10—Published
2003-06-07—Filed